Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study

Further Publications Infectiology

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Lancet Infect Dis

Beran J, Reynales H, Poder A, Yu CY, Pitisuttithum P, Yuan LL, Vermeulen W, Verhoeven C, Leav B, Zhang B, Sawlwin D, Hamers-Heijnen E, Edelman J, Smolenov I

doi: 10.1016/S1473-3099(20)30694-0

Viral Infections, Non-HIV

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Vaccine.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B

doi: 10.1016/j.vaccine.2018.01.045.

Viral Infections, Non-HIV

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

N Engl J Med.

Dunkle LM, Izikson R, Patriarca P, Goldenthal KL, Muse D, Callahan J, Cox MMJ1; PSC Study Team

doi: 10.1056/NEJMoa1608862.

Viral Infections, Non-HIV

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study

Lancet Infect Dis.

Monge S, Hahné SJ, de Melker HE, Sanders EA, van der Ende A, Knol MJ

doi: 10.1016/S1473-3099

Bacterial Infections

Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study

Antimicrob Resist Infect Control.

Segagni Lusignani L, Presterl E, Zatorska B, Van den Nest M, Diab-Elschahawi M

doi: 10.1186/s13756-019-0668-2.

Viral Infections, Non-HIV

Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019

Vaccine.

Castilla J, Portillo ME, Casado I, Pozo F, Navascués A, Adelantado M, Gómez Ibáñez C, Ezpeleta C, Martínez-Baz I, Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarre

doi: 10.1016/j.vaccine.2020.01.028.

Effectiveness of a hospital-wide infection control programme on the incidence of healthcare-associated infections and associated severe sepsis and septic shock: A prospective interventional study

Clin Microbiol Infect.

Hagel S, Ludewig K, Pletz MW, Frosinski J, Moeser A, Wolkewitz M, Gastmeier P, Harbarth S, Brunkhorst FM, Kesselmeier M, Scherag A

doi: 10.1016/j.cmi.2018.07.010.

Viral Infections, Non-HIV

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Lancet Respir Med.

Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD, INSIGHT FLU-IVIG Study Group.

doi: 10.1016/S2213-2600(19)30253-X.

Viral Infections, Non-HIV

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults

Infection.

Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC

doi: 10.1007/s15010-018-1233-2.

Related content

Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older

Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study

Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study

Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019

Effectiveness of a hospital-wide infection control programme on the incidence of healthcare-associated infections and associated severe sepsis and septic shock: A prospective interventional study

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults